Government Schemes and Initiatives for Biotechnology and Medical Research in India

India is expanding its biotechnology and medical research sectors to improve healthcare access, boost domestic manufacturing, and build a competitive bioeconomy. The Department of Biotechnology under the Ministry of Science and Technology, along with the Indian Council of Medical Research under the Ministry of Health and Family Welfare, leads key national programs. These government initiatives provide financial grants, build research infrastructure, fund startups, and support public-private partnerships to advance translational research and clinical trials across the country.

Key Policies and Frameworks

BioE3 Policy

The Union Cabinet approved the BioE3 (Biotechnology for Economy, Environment, and Employment) Policy in August 2024. Implemented by the Department of Biotechnology and Biotechnology Industry Research Assistance Council, this policy focuses on high-performance biomanufacturing. It targets six sectors: bio-based chemicals and enzymes, functional foods and smart proteins, precision biotherapeutics, climate-resilient agriculture, carbon capture and utilization, and futuristic marine and space biomanufacturing. The initiative establishes Moolankur Biofoundries and Biomanufacturing Hubs to help startups and academia scale up production.

National Bioeconomy Target

India aims to grow its bioeconomy to 300 billion dollars by 2030. The strategy combines digital technologies, engineering, and biological sciences to replace fossil-based products with eco-friendly bio-based alternatives.

Major Biotechnology Funding and Startup Schemes

Biotechnology Ignition Grant (BIG)

Managed by BIRAC, the Biotechnology Ignition Grant provides financial support of up to 50 lakh rupees for a period of 18 months. It helps early-stage startups and individual innovators establish proof-of-concept for commercial ideas.

Small Business Innovation Research Initiative (SBIRI)

Launched in 2005, SBIRI supports early-stage research in small and medium-sized biotech enterprises. It provides high-risk venture support for developing indigenous, low-cost technologies.

Biotechnology Industry Partnership Programme (BIPP)

BIPP supports high-risk, cost-shared advanced research in the biotech industry. It funds research in agriculture, healthcare, industrial processes, and environmental solutions, requiring matching funds from industry partners.

Promoting Academic Research Conversion to Enterprise (PACE)

PACE encourages academic institutions to convert lab research into industrial applications. It operates through two components: Academic Innovation Research for early proof-of-concept and Contract Research Scheme for academia-industry research contracts.

Social Innovation Programme for Products: Affordable & Relevant to Healthcare (SPARSH)

SPARSH targets healthcare challenges in rural and resource-poor settings. It offers funding to innovators creating low-cost diagnostic devices, maternal healthcare tools, and assistive technologies.

Infrastructure and Translational Research Support

BioNEST Incubators

BioNEST (Bioincubation Support Scheme) establishes specialized incubation centers across universities, research institutes, and standalone centers. It provides physical space, instrumentation, legal guidance, and business mentoring to biotech startups.

National Biopharma Mission (Innovate in India / i3)

Launched in 2017 with partial funding from the World Bank, the National Biopharma Mission accelerates the development of biopharmaceuticals. Managed by BIRAC, it focuses on domestic development of vaccines, biosimilars, medical devices, and diagnostic kits. It established shared infrastructure facilities, including technology transfer offices and clinical trial networks.

BIRAC Equity and Acceleration Schemes

• SEED Fund provides early-stage equity funding up to 30 lakh rupees to startups incubated at BioNEST centers.
• LEAP Fund provides up to 1 crore rupees in equity funding to growth-stage biotech startups.
• AcE Fund (Accelerating Entrepreneurs) is a fund of funds with a 150 crore rupee corpus that invests through SEBI-registered daughter funds to help biotech startups cross financial hurdles.

Medical Research and Clinical Initiatives

ICMR Medical Research Schemes

The Indian Council of Medical Research funds basic, operational, and clinical research through extra-mural research grants. Key focus areas include communicable diseases, non-communicable diseases, reproductive health, and rare genetic disorders.

Clinical Trials Framework

ICMR and the Department of Health Research established trial networks to accelerate early-phase clinical testing for novel drug molecules and biological products developed within India.

First Hub at BIRAC

First Hub is a single-window facilitation platform established by BIRAC. It helps biotech startups and researchers navigate regulatory approvals from agencies like the Central Drugs Standard Control Organization, Food Safety and Standards Authority of India, and Indian Patent Office.

Key Programs and Targets Summary

Exam-Oriented Facts and Trivia

• Department of Biotechnology was established in 1986 under the Ministry of Science and Technology.
• Biotechnology Industry Research Assistance Council (BIRAC) was set up in 2012 as a Section 8 non-profit Public Sector Enterprise.
• India established its first National Biofoundry Network under the BioE3 policy across academic and research institutions.
• Indian Council of Medical Research (ICMR) originated in 1911 as the Indian Research Fund Association and was renamed in 1949.
• E-YUVA scheme under BIRAC encourages undergraduate and postgraduate students to pursue biotech entrepreneurship.
• SITARE (Students Innovations for Advancement of Research Explorations) provides grants to university-level biotech innovators.
• Grand Challenges India is a joint initiative of DBT, BIRAC, and the Bill & Melinda Gates Foundation to address global health challenges.
• The National Medical Devices Policy provides financial support to boost domestic manufacturing of high-end medical equipment.